APLN and Obesity: In conditions combining obesity and cardiac I/R injury, apelin-13 administration to mice decreased myocardial expression of pro-apoptotic B-cell lymphoma 2 (Bcl-2)-associated X protein and increased the expression of anti-apoptotic Bcl-2, leading to reduced myocardial apoptosis.